Cyclin-Dependent Kinase Inhibitor p57
"Cyclin-Dependent Kinase Inhibitor p57" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME.
Descriptor ID |
D050761
|
MeSH Number(s) |
D12.644.360.225.700 D12.776.167.187.700 D12.776.476.225.700 D12.776.624.776.355.700
|
Concept/Terms |
Cyclin-Dependent Kinase Inhibitor p57- Cyclin-Dependent Kinase Inhibitor p57
- Cyclin Dependent Kinase Inhibitor p57
- p57 KIP2 Protein
- KIP2 Protein, p57
- p57KIP2 Protein
- Cyclin-Dependent Kinase Inhibitor 1C
- Cyclin Dependent Kinase Inhibitor 1C
- Cyclin Kinase Inhibitor Protein 2
- CDKN1C Protein
|
Below are MeSH descriptors whose meaning is more general than "Cyclin-Dependent Kinase Inhibitor p57".
Below are MeSH descriptors whose meaning is more specific than "Cyclin-Dependent Kinase Inhibitor p57".
This graph shows the total number of publications written about "Cyclin-Dependent Kinase Inhibitor p57" by people in this website by year, and whether "Cyclin-Dependent Kinase Inhibitor p57" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclin-Dependent Kinase Inhibitor p57" by people in Profiles.
-
Atypical Presentations of Molar Pregnancy: Diagnostic Roles of Imaging, ß-Human Chorionic Gonadotropin Measurement, and p57 Immunostaining. J Ultrasound Med. 2016 Mar; 35(3):643-9.
-
Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells. Mol Cancer. 2015 Oct 13; 14:180.
-
Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome. Nat Genet. 2012 May 27; 44(7):788-92.
-
Down-regulation of p57Kip2 induces prostate cancer in the mouse. Cancer Res. 2008 May 15; 68(10):3601-8.